Sponsors (2 505)

search
business
South Korea
assignment1trial

Songpa, South Korea

Therapeutic Areas

Immune system disorders

Diseases

Myasthenia gravis

Interventions

HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
business
Spain
assignment2trials

Azuqueca de henares, Spain

Therapeutic Areas

Respiratory, thoracic and mediastinal disorders

Diseases

Chronic obstructive pulmonary disease
business
Switzerland
assignment1trial

Buonas, Switzerland

Therapeutic Areas

Immune system disorders

Diseases

Psoriasis
business
Canada
assignment1trial

London, Canada

Therapeutic Areas

Infections and infestations

Diseases

Post-acute COVID-19 syndrome

Interventions

Cellulose, Microcrystalline
business
South Korea
assignment1trial

Seongnam-si, South Korea

Therapeutic Areas

Immune system disorders

Diseases

Chronic graft versus host disease
business
United Kingdom
assignment1trial

Cardiff, United Kingdom

Therapeutic Areas

Psychiatric disorders

Diseases

Major depression
business
Sweden
assignment1trial

Vastra frolunda, Sweden

Therapeutic Areas

Investigations

Diseases

Corticobasal degeneration
business
United States
assignment1trial

Boston, United States

Therapeutic Areas

Infections and infestations

Diseases

Fungal infection

Interventions

Amphotericin B
business
United States
assignment2trials

Boston, United States

Therapeutic Areas

Immune system disorders

Diseases

Chronic obstructive pulmonary disease
business
United Kingdom
assignment1trial

Abingdon, United Kingdom

Therapeutic Areas

Neoplasms benign, malignant and unspecified (incl cysts and polyps)

Diseases

Renal cell carcinoma

Interventions

Nivolumab
business
Switzerland
assignment1trial

Muttenz, Switzerland

Therapeutic Areas

Renal and urinary disorders

Diseases

Chronic kidney disease
business
The Netherlands
assignment1trial

Baarn, The Netherlands

Therapeutic Areas

Ear and labyrinth disorders

Diseases

Meniere's disease

Need more than the directory?

Competitive positioning, market entry, partnership opportunities — tell us the question.